PhaseBio Pharmaceuticals Net Income Growth

Net Income Growth of PHAS for past 10 years: annual, quarterly and twelve month trailing (TTM) including Net Income Growth growth rates and interactive chart.


Highlights and Quick Summary

  • Net Income Growth for the quarter ending March 31, 2022 was 0.59 (a -241.38% decrease compared to previous quarter)
  • Year-over-year quarterly Net Income Growth decreased by -3203.66%
  • Annual Net Income Growth for 2021 was -0.33 (a -78.18% decrease from previous year)
  • Annual Net Income Growth for 2020 was -1.51 (a 134.0% increase from previous year)
  • Annual Net Income Growth for 2019 was -0.65 (a -51.33% decrease from previous year)
Visit stockrow.com/PHAS for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Net Income Growth of PhaseBio Pharmaceuticals

Most recent Net Income Growthof PHAS including historical data for past 10 years.

Interactive Chart of Net Income Growth of PhaseBio Pharmaceuticals

PhaseBio Pharmaceuticals Net Income Growth for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 0.59
2021 -0.42 -0.27 -0.02 -0.84 -0.33
2020 -1.68 -1.21 -2.05 -1.04 -1.51
2019 -1.33 -0.44 -0.38 -0.66 -0.65
2018 -0.9 0.31 0.28 0.4 -1.33
2017 0.47 -0.11
2016 0.1

Business Profile of PhaseBio Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology